3American Joint Committee on Cancer.AJCC Cancer Staging Handbook[M].7th ed.Chicago:Springer,2010:417-60.
4Carter C L,Allen C,Henson D E.Relation of tumor size,lymph node status,and survival in 24,740 breast cancer cases[J].Cancer,1989,63(1):181-7.
5Mansel R E,Fallowfield L,Kissin M,et al.Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer:the ALMANAC Trial[J].J Natl Cancer Inst,2006,98(9):599-609.
6Calhoun K E,Hansen N M,Turner R R,et al.Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node:implications for completion axillary node dissection[J].Am J Surg,2005,190(4):588-91.
7Cserni G,Gregori D,Merletti F,et al.Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer[J].Br J Surg,2004,91(10):1245-52.
8Sneige N,Wang J,Baker B A.Clinical,histopathologic,and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast:a report of 24 cases[J].Mod Pathol,2002,15(10):1044-50.
9Ellis I O,Schnitt S J,Sastre-Garau X,et al.Invasive breast carcinoma[M]//Tavassoli F A,Devilee P.World Health Organization Classification of Tumours.Pathology and genetics of tumours of the breast and female genital organs.Lyon:IARC Press,2003:13-59.
10Elston C W,Ellis I O.Pathological prognostic factors in breast cancer.I.The value of histological grade in breast cancer:experience from a large study with long-term follow-up[J].Histopathology,1991,19(5):403-10.
